DiaKine Therapeutics' Angel Round

DiaKine Therapeutics raised a round of funding on , . Investors include BlueTree Allied Angels.

DiaKine Therapeutics, Inc. is a development-stage company commercializing immune modulators such as Lisofylline (LSF) and related oral compounds into therapies for diabetes and related complications. …

Articles about DiaKine Therapeutics' Angel Round: